Skip to NavigationSkip to content

News

NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended for use on the...
Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that the companies ran bribery schemes...
More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, according to a recent...
In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended...
The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is not safe to relax social distancing...
AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University...
Novartis’ Mayzent (siponimod) has been unsuccessful in securing a recommendation from NICE for use on the NHS for the treatment of secondary...
A new study has highlighted how human biases affect the regulatory approval process of the FDA.
Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, experts have warned.
The National Institutes of Health had its funding cut from a research project into bat coronavirus, according its Director Dr Anthony Fauci.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches